SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 73 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.20 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $255,000 | -69.8% | 594,108 | +129.7% | 0.00% | -71.4% |
| Q1 2021 | $843,000 | -68.6% | 258,662 | -67.1% | 0.01% | -70.8% |
| Q4 2020 | $2,681,000 | -40.2% | 786,255 | -28.5% | 0.02% | -48.9% |
| Q3 2020 | $4,487,000 | +54.7% | 1,099,695 | +28.1% | 0.05% | +51.6% |
| Q2 2020 | $2,901,000 | +385.9% | 858,247 | +235.1% | 0.03% | +287.5% |
| Q1 2020 | $597,000 | -45.7% | 256,085 | -15.2% | 0.01% | -27.3% |
| Q4 2019 | $1,099,000 | +25.5% | 301,874 | +156.6% | 0.01% | -42.1% |
| Q2 2017 | $876,000 | -36.8% | 117,647 | -44.8% | 0.02% | -32.1% |
| Q1 2017 | $1,386,000 | +607.1% | 213,247 | +381.4% | 0.03% | +600.0% |
| Q4 2016 | $196,000 | -87.5% | 44,300 | -81.4% | 0.00% | -87.5% |
| Q2 2016 | $1,563,000 | +376.5% | 237,901 | +361.6% | 0.03% | +357.1% |
| Q1 2016 | $328,000 | +245.3% | 51,540 | +226.2% | 0.01% | +250.0% |
| Q4 2015 | $95,000 | +37.7% | 15,800 | +36.2% | 0.00% | +100.0% |
| Q3 2015 | $69,000 | -59.2% | 11,600 | -48.7% | 0.00% | -66.7% |
| Q2 2013 | $169,000 | – | 22,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 6,963,756 | $145,960,000 | 9.42% |
| Avoro Capital Advisors LLC | 3,419,818 | $71,679,000 | 2.76% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 300,000 | $6,285,000 | 2.41% |
| Cormorant Asset Management, LP | 1,200,000 | $25,152,000 | 1.86% |
| Sio Capital Management, LLC | 143,550 | $3,009,000 | 1.66% |
| ASHFORD CAPITAL MANAGEMENT INC | 425,702 | $8,923,000 | 1.18% |
| PURA VIDA INVESTMENTS, LLC | 130,700 | $2,739,000 | 1.10% |
| Sonora Investment Management, LLC | 298,967 | $6,266,000 | 0.97% |
| PURA VIDA INVESTMENTS, LLC | 100,000 | $2,096,000 | 0.84% |
| J. Goldman & Co LP | 694,338 | $14,553,000 | 0.75% |